Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Crist

Showing results (11-20 of 90) with videos related to

Pageof 9
Sort By:
Journal of the Air & Waste Management Association (1995)|January 2, 2007
The Steubenville Comprehensive Air Monitoring Program (SCAMP): concentrations and solubilities of PM(2.5) trace elements and their implications for source apportionment and health researchDaniel P Connell, Stephen E Winter, Vincent B Conrad, et al.
Neuroscience Research|November 10, 2021
Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: Implications for Alzheimer's diseaseAndrew E Weller, Glenn A Doyle, Benjamin C Reiner, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2020
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid CrisisAndrew E Weller, Richard C Crist, Benjamin C Reiner, et al.
Molecular Psychiatry|January 9, 2019
The importance of buprenorphine research in the opioid crisisSarah A Pendergrass, Richard C Crist, Laney K Jones, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2011
Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Michael P Lisanti, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Addiction Biology|March 1, 2022
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trialsHenry R Kranzler, Richard Feinn, Timothy Pond, et al.
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Addiction (Abingdon, England)|January 6, 2023
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trialVictoria R Votaw, Katie Witkiewitz, M Lee Van Horn, et al.
Drug and Alcohol Dependence|May 28, 2021
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorderHenry R Kranzler, Emily E Hartwell, Richard Feinn, et al.
Pageof 9

Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Journal of the Air & Waste Management Association (1995)|January 2, 2007
The Steubenville Comprehensive Air Monitoring Program (SCAMP): concentrations and solubilities of PM(2.5) trace elements and their implications for source apportionment and health researchDaniel P Connell, Stephen E Winter, Vincent B Conrad, et al.
Neuroscience Research|November 10, 2021
Analysis of differential gene expression and transcript usage in hippocampus of Apoe null mutant mice: Implications for Alzheimer's diseaseAndrew E Weller, Glenn A Doyle, Benjamin C Reiner, et al.
Cold Spring Harbor Perspectives in Medicine|April 2, 2020
Neonatal Opioid Withdrawal Syndrome (NOWS): A Transgenerational Echo of the Opioid CrisisAndrew E Weller, Richard C Crist, Benjamin C Reiner, et al.
Molecular Psychiatry|January 9, 2019
The importance of buprenorphine research in the opioid crisisSarah A Pendergrass, Richard C Crist, Laney K Jones, et al.
Cell Cycle (Georgetown, Tex.)|March 10, 2011
Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min) -mediated intestinal tumorigenesisRichard C Crist, Jacquelyn J Roth, Michael P Lisanti, et al.
The American Journal of Drug and Alcohol Abuse|January 16, 2018
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rateRichard C Crist, James Li, Glenn A Doyle, et al.
Addiction Biology|March 1, 2022
Post-treatment effects of topiramate on alcohol-related outcomes: A combined analysis of two placebo-controlled trialsHenry R Kranzler, Richard Feinn, Timothy Pond, et al.
The American Journal of Drug and Alcohol Abuse|October 29, 2025
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorderRachel Vickers-Smith, Richard C Crist, Rachel L Kember, et al.
Addiction (Abingdon, England)|January 6, 2023
An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trialVictoria R Votaw, Katie Witkiewitz, M Lee Van Horn, et al.
Drug and Alcohol Dependence|May 28, 2021
Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorderHenry R Kranzler, Emily E Hartwell, Richard Feinn, et al.
Pageof 9